Vascular disrupting agent

This page covers all Vascular disrupting agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Tubulin.

Targets

Tubulin

Phase 3 pipeline (1)

• Ombrabulin (AVE8062) · Sanofi · Oncology
  Ombrabulin is a vascular disrupting agent that binds to tubulin and disrupts microtubule dynamics, causing selective destruction of tumor vasculature and tumor cell death.